drugset / Trial / NCT05327699
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
Phase 0
Recruiting
140 enrolled
Emory University
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupTriple-blindOther
Summary
The main purpose of this study is to investigate the effects of ketamine on decision-making and emotion processing in a sample of individuals diagnosed with Major Depressive Disorder (MDD).
Timeline
- Start
- 2022-11-08
- Primary completion
- 2028-03-02
- Completion
- 2028-03-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.5 mg/kg | Intravenous |